Your browser doesn't support javascript.
loading
Tumor mutational burden assessment in non-small-cell lung cancer samples: results from the TMB2 harmonization project comparing three NGS panels.
Ramos-Paradas, Javier; Hernández-Prieto, Susana; Lora, David; Sanchez, Elena; Rosado, Aranzazu; Caniego-Casas, Tamara; Carrizo, Nuria; Enguita, Ana Belén; Muñoz-Jimenez, María Teresa; Rodriguez, Borja; Perez-Gonzalez, Urbicio; Gómez-Sánchez, David; Ferrer, Irene; Ponce Aix, Santiago; Nuñez Buiza, Ángel; Garrido, Pilar; Palacios, José; Lopez-Rios, Fernando; Garrido-Martin, Eva M; Paz-Ares, Luis.
Afiliação
  • Ramos-Paradas J; H12O-CNIO Lung Cancer Clinical Research Unit, Health Research Institute Hospital 12 de Octubre (imas12) / Spanish National Cancer Research Center (CNIO), Madrid, Spain.
  • Hernández-Prieto S; Spanish Center for Biomedical Research Network in Oncology (CIBERONC), Madrid, Spain.
  • Lora D; Pathology-Targeted Therapies Laboratory, HM Sanchinarro University Hospital, Madrid, Spain.
  • Sanchez E; Scientific Support Unit, Health Research Institute Hospital 12 de Octubre (imas12), Madrid, Spain.
  • Rosado A; Spanish Center for Biomedical Research Network in Epidemiology and Public Health (CIBERESP), Madrid, Spain.
  • Caniego-Casas T; Faculty of Statistical Sciences, Complutense University, Madrid, Spain.
  • Carrizo N; Pathology-Targeted Therapies Laboratory, HM Sanchinarro University Hospital, Madrid, Spain.
  • Enguita AB; H12O-CNIO Lung Cancer Clinical Research Unit, Health Research Institute Hospital 12 de Octubre (imas12) / Spanish National Cancer Research Center (CNIO), Madrid, Spain.
  • Muñoz-Jimenez MT; Pathology Department, Ramón y Cajal Hospital, IRYCIS, Madrid, Spain.
  • Rodriguez B; H12O-CNIO Lung Cancer Clinical Research Unit, Health Research Institute Hospital 12 de Octubre (imas12) / Spanish National Cancer Research Center (CNIO), Madrid, Spain.
  • Perez-Gonzalez U; Pathology Department, 12 de Octubre Hospital, Madrid, Spain.
  • Gómez-Sánchez D; H12O-CNIO Lung Cancer Clinical Research Unit, Health Research Institute Hospital 12 de Octubre (imas12) / Spanish National Cancer Research Center (CNIO), Madrid, Spain.
  • Ferrer I; H12O-CNIO Lung Cancer Clinical Research Unit, Health Research Institute Hospital 12 de Octubre (imas12) / Spanish National Cancer Research Center (CNIO), Madrid, Spain.
  • Ponce Aix S; Medical Oncology Department, 12 de Octubre Hospital, Madrid, Spain.
  • Nuñez Buiza Á; H12O-CNIO Lung Cancer Clinical Research Unit, Health Research Institute Hospital 12 de Octubre (imas12) / Spanish National Cancer Research Center (CNIO), Madrid, Spain.
  • Garrido P; Spanish Center for Biomedical Research Network in Oncology (CIBERONC), Madrid, Spain.
  • Palacios J; H12O-CNIO Lung Cancer Clinical Research Unit, Health Research Institute Hospital 12 de Octubre (imas12) / Spanish National Cancer Research Center (CNIO), Madrid, Spain.
  • Lopez-Rios F; Spanish Center for Biomedical Research Network in Oncology (CIBERONC), Madrid, Spain.
  • Garrido-Martin EM; H12O-CNIO Lung Cancer Clinical Research Unit, Health Research Institute Hospital 12 de Octubre (imas12) / Spanish National Cancer Research Center (CNIO), Madrid, Spain.
  • Paz-Ares L; Spanish Center for Biomedical Research Network in Oncology (CIBERONC), Madrid, Spain.
J Immunother Cancer ; 9(5)2021 05.
Article em En | MEDLINE | ID: mdl-33963008

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Análise Mutacional de DNA / Biomarcadores Tumorais / Carcinoma Pulmonar de Células não Pequenas / Sequenciamento de Nucleotídeos em Larga Escala / Neoplasias Pulmonares / Mutação Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: J Immunother Cancer Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Espanha

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Análise Mutacional de DNA / Biomarcadores Tumorais / Carcinoma Pulmonar de Células não Pequenas / Sequenciamento de Nucleotídeos em Larga Escala / Neoplasias Pulmonares / Mutação Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: J Immunother Cancer Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Espanha